PropertyValue
?:abstract
  • The CR3022 antibody, selected from a group of SARS-CoV monoclonal antibodies for its ability to cross-react with SARS-CoV-2, has been examined for its ability to bind to the ectodomain of the SARS-CoV-2 spike glycoprotein. Using cryo-electron microscopy we show that antibody binding requires rearrangements in the S1 domain that result in dissociation of the spike.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1038/s41467-020-19146-5
?:journal
  • Nat_Commun
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/7791f82f9a68ed3721ff57722c3b9ffade01cff8.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7577971.xml.json
?:pmcid
?:pmid
?:pmid
  • 33087721.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
?:type
?:year
  • 2020-10-21

Metadata

Anon_0  
expand all